So, virtual neurology appointment yesterday. Standard questions, and then at the end he mentioned a November study of Mayzent users who were vaccinated for the regular flu.
There was no data specifically for covid, but for the type-A flu, 92% of the control group got protective antibodies, but only 74% for Mayzent.
Type-B: 43% control, 26% Mayzent.
Pneumonia: 100% control, 100% Mayzent. Cool.
So that explains why we weren’t in the early trials — we would have dropped the numbers.
(If you are curious, Gilenya numbers are worse.)
I believe his recommendation was “Be vigilant and wait out the Covid.” So, I can’t relax even after I get fully vaccinated. And I’ll have to be a fragile flower.
Maybe there are enough fragile flowers that we can get an extra booster shot? Maybe?